Peter Kim is a highly educated and experienced professional in the fields of biochemistry, biotech equity research, and life sciences strategy consulting. He holds a Doctor of Philosophy (Ph.D.) in Biochemistry from Yale University and a B.S./M.S. in Biochemistry from the University of California, San Diego.

Kim has held various positions in investment analysis, including his current role as an Investment Analyst at Stratome Capital Management. He has also served as Vice President of Biotech Equity Research at Barclays and Senior Research Associate of Biotech Equity Research at AB Bernstein. Prior to this, Kim gained experience in life sciences strategy consulting at L.E.K. Consulting and worked as a Summer Consultant at Boston Consulting Group (BCG). He began his professional career as a Research Associate at Bio Architecture Lab.

Kim's impressive background and diverse experience have provided him with extensive knowledge and expertise in the areas of biochemistry, biotech equity research, and life sciences strategy consulting. He is a valuable asset to any organization seeking a highly-skilled professional in these fields.